Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Topcon Healthcare Announces the U.S. Launch of Aladdin-M

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Sutter Health and Allina Health Sign...

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to...

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following...

US-based medical device company Artivion has completed its acquisition...

Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced that it has launched its new Aladdin-M instrument to the US market. Aladdin-M combines corneal topography, pupillometry, and optical biometry to enable objective measurement of corneal curvature, pupil dynamics, and axial length metrics.

The versatile, all-in-one Aladdin-M provides the critical tools needed to support myopia management while also incorporating features for keratoconus screening and contact lens fitting. Aladdin-Mโ€™s exclusive software enables documentation of axial length measurements to identify risk factors and track changes in Rx and axial length measurements over time to show progression and response to treatment. The instrument is compact, easy to operate, and offers rapid capture to ensure patient satisfaction.

It is estimated that 50% of the worldโ€™s population may be myopic by 20501. With the launch of Aladdin-M, Topcon achieves a milestone in supporting the battle against this global myopia epidemic.

โ€œAladdin-M is ideally suited to help eye care professionals combat the growing crisis of myopia. Its versatility and ease of use allow eye care professionals to easily build a myopia service within their practice, educate patients on the implications of myopia, manage their patientsโ€™ conditions, and grow their service offerings,โ€ stated John Trefethen, Global VP of Marketing & Product Design for Topcon Healthcare.

Topcon will debut the Aladdin-M device at the Vision Source Exchange On-Demand meeting, August 27th โ€“ 29th.

About Topcon Healthcare

Topcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever-changing landscape of the healthcare industry, we offer the latest integrated solutions, including advanced multimodal imaging, vendor-neutral data management, and ground-breaking remote diagnostic technology.

A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare, and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and high quality of life.

Never miss a healthcare headline

Healthcare moves fast โ€“ stay on top of it with our must - read briefings.

  • The top hospital and healthcare stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments transforming global healthcare management
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Sutter Health and Allina Health Sign Definitive Agreement to Join Forces

Sutter Health and Allina Health, both nonprofit health systems,...

GHO Capital and CBC Group to Build the Largest Pan-Asian Healthcare Investment Platform

Two of the world's prominent healthcare-focused investment firms London-based...

Artivion Acquires Endospan for $135M Following FDA Approval of NEXUS Aortic Graft Stent System

US-based medical device company Artivion has completed its acquisition...

NHS Plans Single Patient Record to Transform Healthcare

The National Health Service is moving forward with plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป